Alira Health Announces Its Role as Strategic Advisor to Naxicap
July 21, 2021
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
The Alira Health strategic, commercial, and regulatory due diligence teams brought their expertise and market insights to analyze the diversified product portfolio of Ceres and the various geographies it is operating in.
We are pleased that Naxicap was able to become the new significant shareholder of Ceres and that Alira Health was part of the effort. The opportunities for Ceres going forward are tremendous and the growth both in Benelux and in Central Europe will certainly be significant.”
Subscribe to our newsletter for the latest news, events, and thought leadership